AI-generated summary
The authors randomized 60 hematopoietic stem cell transplant patients to intraoral or extraoral photobiomodulation to prevent oral mucositis. They report that extraoral treatment was as effective as intraoral treatment, with shorter session times, and that 58.3% of patients developed ulcerated mucositis. The study was single-blind and the abstract does not describe a placebo control group.
- Participants
- 60
- Who or what was studied
- Patients undergoing hematopoietic stem cell transplantation (HSCT)
- Limits stated in the abstract
- The abstract does not state a placebo control group, and it does not report wavelengths or dosimetry parameters.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Photobiomodulation therapy, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.